Globus Medical (GMED) Price to Earnings (2012 - 2026)

Globus Medical (GMED) has reported Price to Earnings for 15 consecutive years, with 69.99 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Earnings rose 78.1% year-over-year to 69.99; the trailing twelve-month figure through Jun 2026 stood at 19.81 (down 11.35% YoY), and the FY2025 full-year result was 21.96, down 80.12% from the prior year.
• Price to Earnings eased to 69.99 in Q2 2026 per GMED's latest filing, from 94.09 in the prior quarter.
• Across five years, Price to Earnings topped out at 6994.78 in Q3 2023 and bottomed at 1011.94 in Q1 2024.
• Historically, Price to Earnings has averaged 485.12 across 5 years, with a median of 120.53 in 2022.
• The sharpest annual moves came in 2023 and 2024: Price to Earnings jumped 5478.19% in 2023, then plunged 974.83% in 2024.
• Over 5 years, Price to Earnings stood at 232.97 in 2022, then surged by 105.97% to 479.85 in 2023, then retreated by 10.55% to 429.2 in 2024, then sank by 80.43% to 83.99 in 2025, then retreated by 16.67% to 69.99 in 2026.
• According to Business Quant data, Price to Earnings over the past three periods registered 69.99, 94.09, and 83.99 for Q2 2026, Q1 2026, and Q4 2025 respectively.